We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Cariprazine

News List

Zydus Cadila receives tentative approval from US FDA for Cariprazine Capsule expresspharma
December 13, 2021
Zydus’s Cariprazine Capsules are indicated for the treatment of schizophrenia and acute treatment of manic or mixed episodes associated with bipolar disorder.
FDA Approves Expanded Use of Vraylar (cariprazine) in the Treatment of Bipolar Depression drugs
June 04, 2019
FDA Approves Expanded Use of Vraylar (cariprazine) in the Treatment of Bipolar Depression.
Allergan and Gedeon Richter Receive U.S. FDA Approval For Expanded Use of Vraylar (cariprazine) in the Treatment of Bipolar Depression drugs
May 29, 2019
Allergan and Gedeon Richter Receive U.S. FDA Approval For Expanded Use of Vraylar (cariprazine) in the Treatment of Bipolar Depression.
FDA accepts Allergan’s Vraylar for review pharmatimes
September 29, 2018
The US Food and Drug Administration has accepted for review an application from Allergan to expand the scope of its antipsychotic Vraylar.